非酒精性脂肪性肝病与冠状动脉易损斑块的关系研究

doi:10.12114/j.issn.1007-9572.2018.31.010

摘要/Abstract

摘要： 目的　探讨非酒精性脂肪性肝病（NAFLD）是否是冠状动脉易损斑块的高危人群。方法　连续纳入2011-01-01至2015-01-30四川省内江市第一人民医院住院期间曾行冠状动脉CT造影并且3个月内曾行腹部CT的患者，记录基线资料、临床诊断，根据病史及影像学指标分为NAFLD组与非NAFLD组，根据2016美国冠状动脉CT专家共识分析冠状动脉，判断有无易损斑块，记录易损斑块的数量和狭窄评分。结果　纳入本研究的患者有603例，其中NAFLD组124例，非NAFLD组479例，185（30.7%）例患者冠状动脉CT造影有易损斑块。NAFLD组易损斑块的比例高于非NAFLD组（46.0%比26.7%，P<0.001）；NAFLD组有≥2个易损斑块的患者比例高于非NAFLD组（12.9%比5.4%，P=0.004）；NAFLD组狭窄≥50%的易损斑块比例高于非NAFLD组（29.0%比13.6%，P<0.001）。多因素Logistic回归分析结果显示NAFLD是冠状动脉易损斑块的危险因素〔OR（95%CI）=2.12（1.37，3.26），P=0.001）〕。结论　NAFLD患者是冠状动脉易损斑块的高危人群。

关键词: 冠状动脉疾病, 非酒精性脂肪性肝病, 易损斑块, 冠状动脉CT造影

Abstract: Objective　To determine whether nonalcoholic fatty liver disease （NAFLD） patients are at high risk of vulnerable coronary artery plaques.Methods　We enrolled the consecutive inpatients who underwent coronary artery CT angiography （CCTA） and abdominal CT （within 3 months before or after CCTA） in the First People's Hospital of Neijiang from January 1，2011 to January 30，2015.We collected their baseline and clinical data （including diagnosis and imaging results） and divided them into NAFLD and non-NAFLD groups according to the medical history and imaging findings.We performed an analysis of the CCTA results based on CAD-RADS（an expert consensus document issued by SCCT，ACR and NASCI in 2016）.Vulnerable plaques were determined，counted and recorded，and the CAD-RADS score was recorded.Results　Totals of 603 cases were included in the study，including 124 with NAFLD and 479 without.185 （30.7% of the total） presented vulnerable plaques in CCTA.Compared with non-NAFLD patients，NAFLD patients had a higher prevalence of vulnerable plaques（46.0% vs 26.7%，P<0.001），and a higher prevalence of multiple（≥2） vulnerable plaques （12.9% vs 5.4%，P=0.004），as well as a higher prevalence of carotid stenosis of ≥50% （caused by vulnerable plaques）（29.0% vs 13.6%，P<0.001）.Multivariate Logistic regression analysis suggested that NAFLD is a risk factor for vulnerable coronary artery plaques 〔OR（95%CI）=2.12（1.37，3.26），P=0.001）〕.Conclusion　NAFLD patients are a high-risk group for vulnerable coronary artery plaques.

Key words: Coronary artery disease, Nonalcoholic fatty liver disease, Vulnerable plaque, Coronary CT angiography

杨小艳,杨勇,张旭,等. 非酒精性脂肪性肝病与冠状动脉易损斑块的关系研究[J]. 中国全科医学, 2018, 21(31): 3827-3831. DOI: 10.12114/j.issn.1007-9572.2018.31.010.
YANG Xiaoyan,YANG Yong,ZHANG Xu, et al. Relationship between Nonalcoholic Fatty Liver Disease and Vulnerable Coronary Artery Plaques[J]. Chinese General Practice, 2018, 21(31): 3827-3831. DOI: 10.12114/j.issn.1007-9572.2018.31.010.

参考文献

［1］WONG V W，CHU W C，WONG G L，et al．Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese：a population study using proton-magnetic resonance spectroscopy and transient elastography［J］．Gut，2012，61（3）：409-415.
［2］MIN J K，SHAW L J，DEVEREUX R B，et al．Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality［J］．J Am Coll Cardiol，2007，50（12）：1161-1170.
［3］MCGOVERN P G，PANKOW J S，SHAHAR E，et al．Recent trends in acute coronary heart disease：mortality，morbidity，medical care，and risk factors.The Minnesota Heart Survey Investigators［J］．N Engl J Med，1996，334（14）：884-890.
［4］温静．心电图aVR导联ST段抬高对急性冠脉综合征患者长期预后的评估价值研究［J］．实用心脑肺血管病杂志，2016，24（5）：31-34．DOI：10.3969/j.issn.1008-5971.2016.05.007.
WEN J．Role of lead aVR ST-segment elevation of ECG in the prediction of long-term prognosis of patients with acute coronary syndrome［J］．Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease，2016，24 （5）：31-34．DOI：10.3969/j.issn.1008-5971.2016.05.007.
［5］PFLEDERER T，MARWAN M，SCHEPIS T，et al．Characterization of culprit lesions in acute coronary syndromes using coronary dual-source CT angiography［J］．Atherosclerosis，2010，211（2）：437-444.
［6］PUNDZIUTE G，SCHUIJF J D，JUKEMA J W，et al．Evaluation of plaque characteristics in acute coronary syndromes：non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis［J］．European Heart Journal，2008，29（19）：2373-2381.
［7］SATO A，OHIGASHI H，NOZATO T，et al．Coronary artery spatial distribution，morphology，and composition of nonculprit coronary plaques by 64-slice computed tomographic angiography in patients with acute myocardial infarction［J］．The American Journal of Cardiology，2010，105（7）：930-935.
［8］YANG X，GAI L，DONG W，et al．Characterization of culprit lesions in acute coronary syndromes compared with stable angina pectoris by dual-source computed tomography［J］．The International Journal of Cardiovascular Imaging，2013，29（4）：945-953.
［9］HOFFMANN U，MOSELEWSKI F，NIEMAN K，et al．Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography［J］．Journal of the American College of Cardiology，2006，47（8）：1655-1662.
［10］葛均波，徐永健.内科学［M］．8版.北京：人民卫生出版社，2013：409.
［11］CURY R C，ABBARA S，ACHENBACH S，et al．CAD-RADSTM coronary artery disease–reporting and data system.An expert consensus document of the Society of Cardiovascular Computed Tomography （SCCT），the American College of Radiology （ACR） and the North American Society for Cardiovascular Imaging （NASCI）．Endorsed by the American College of Cardiology［J］．Journal of Cardiovascular Computed Tomography，2016，10（4）：269-281.
［12］PUCHNER S B，LIU T，MAYRHOFER T，et al．High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain［J］．Journal of the American College of Cardiology，2014，64（7）：684-692.
［13］MOTOYAMA S，SARAI M，HARIGAYA H，et al．Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome［J］．J Am Coll Cardiol，2009，54（1）：49-57.
［14］MOTOYAMA S，ITO H，SARAI M，et al．Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up［J］．J Am Coll Cardiol，2015，66（4）：337-346.
［15］MOTOYAMA S，KONDO T，SARAI M，et al．Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes［J］．J Am Coll Cardiol，2007，50（4）：319-326.
［16］INOUE K，MOTOYAMA S，SARAI M，et al．Serial coronary CT angiography-verified changes in plaque characteristics as an end point［J］．JACC：Cardiovascular Imaging，2010，3（7）：691-698.
［17］OTSUKA K，FUKUDA S，TANAKA A，et al．Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome［J］．JACC Cardiovasc Imaging，2013，6（4）：448-457.
［18］ONI E T，AGATSTON A S，BLAHA M J，et al．A systematic review：burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver；should we care?［J］．Atherosclerosis，2013，230（2）：258-267.
［19］KIM D，CHOI S Y，PARK E H，et al．Nonalcoholic fatty liver disease is associated with coronary artery calcification［J］．Hepatology，2012，56（2）：605-613.
［20］LABRECQUE D R，ABBAS Z，ANANIA F，et al．World Gastroenterology Organisation global guidelines：nonalcoholic fatty liver disease and nonalcoholic steatohepatitis［J］．J Clin Gastroenterol，2014，48（6）：467-473.
［21］ARBAB-ZADEH A，NAKANO M，VIRMANI R，et al．Acute coronary events［J］．Circulation，2012，125（9）：1147-1156.
［22］OSAWA K，MIYOSHI T，YAMAUCHI K，et al．Nonalcoholic hepatic steatosis is a strong predictor of high-risk coronary-artery plaques as determined by multidetector CT［J］．PLoS One，2015，10（6）：e131138.
［23］PUCHNER S B，LU M T，MAYRHOFER T，et al．High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease，independent of coronary plaque and stenosis burden：results from the ROMICATⅡtrial［J］．Radiology，2015，274（3）：693-701.
［24］AKABAME S，HAMAGUCHI M，TOMIYASU K，et al．Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease （NAFLD） by 64-detector multislice computed tomography （MSCT）［J］．Circ J，2008，72（4）：618-625.

[1]	王丽娜, 高鹏飞, 曹帆, 葛莹, 颜维, 何岱昆. 不同性别人群非酒精性脂肪性肝病患病现况及影响因素分析[J]. 中国全科医学, 2023, 26(33): 4143-4151.
[2]	袁铭培, 林耀望, 贝伟杰, 刘华东, 董少红, 孙鑫. 经远端桡动脉入径逆向开通闭塞桡动脉的可行性：单中心前瞻性研究[J]. 中国全科医学, 2023, 26(27): 3373-3377.
[3]	蔡高军, 师干伟, 李峰, 李文华, 严永敏, 薛社亮, 肖建强, 顾君, 宋艳斌, 张刘燕, 卢伟, 龚春. 如何提高经远端桡动脉入径穿刺成功率、"曲径通幽"？基于两千余病例的经验总结[J]. 中国全科医学, 2023, 26(27): 3361-3365.
[4]	刘明浩, 王攀, 高立建, 徐淑清, 王欢欢, 赵光贤, 陈珏, 乔树宾, 徐波, 袁晋青. 经远端桡动脉入径行二次经皮冠状动脉介入治疗的可行性、安全性和手术时机研究[J]. 中国全科医学, 2023, 26(27): 3366-3372.
[5]	兰永昊, 科尔沁, 韩蕊, 梅迎晨, 刘巍. 经远端桡动脉入径行经皮冠状动脉介入治疗：优势、劣势、机遇和挑战[J]. 中国全科医学, 2023, 26(27): 3355-3360.
[6]	高扬, 王贇霞, 张优, 高传玉. ≤45岁急性冠脉综合征患者中超高危冠状动脉粥样硬化性心脏病人群降脂治疗后血脂达标率及影响因素研究[J]. 中国全科医学, 2023, 26(27): 3383-3387.
[7]	孔德先, 邢煜玲, 孙文文, 张智敏, 周霏, 马慧娟. 预估葡萄糖处理率与2型糖尿病合并代谢相关脂肪性肝病的相关性研究[J]. 中国全科医学, 2023, 26(26): 3252-3258.
[8]	陈焱, 吕智博, 赵昕. 残粒脂蛋白胆固醇及非高密度脂蛋白胆固醇水平不一致性与冠状动脉狭窄严重程度的相关性研究[J]. 中国全科医学, 2023, 26(24): 3010-3015.
[9]	高哲, 段凯欣, 吕秀芹, 马慧娟, 张志梅, 宋光耀. 胰高血糖素样肽-1受体激动剂改善高果糖饮食诱导的胰岛素抵抗大鼠肝脏脂质沉积机制研究[J]. 中国全科医学, 2023, 26(21): 2639-2646.
[10]	张卓然, 于长禾, 安易, 何新, 郭一, 邓金燕, 李悦, 韩登, 皮珊珊, 贺俊芝, 陈玥, 叶永安, 杜宏波. 非酒精性脂肪性肝病临床指南和共识的质量评价及推荐意见比较研究[J]. 中国全科医学, 2023, 26(20): 2439-2446.
[11]	钱方方, 蔡珍生, 顾恬, 李昊翔, 赵丽, 杨玲, 邓霞, 袁国跃. 2型糖尿病患者血清Ectodysplasin A与非酒精性脂肪性肝病相关性研究[J]. 中国全科医学, 2023, 26(08): 911-916.
[12]	时学秀, 贠文晶, 王海旭, 赵颖颖, 杨亚楠, 孙同文. 垂体功能减退症合并肝硬化临床特征研究[J]. 中国全科医学, 2023, 26(06): 699-703.
[13]	傅伟强, 周剑波, 吴雄健, 黄才斌. 肠道菌群视角下非酒精性脂肪性肝病的治疗策略[J]. 中国全科医学, 2023, 26(06): 742-748.
[14]	丛方远, 薛倩, 邓利华, 朱蕗颖, 王晶桐. 非酒精性脂肪性肝病与左心室早期舒张功能不全的相关性研究[J]. 中国全科医学, 2022, 25(26): 3290-3297.
[15]	马纪林, 张雪平. 单核细胞与高密度脂蛋白胆固醇比值对社区居民非酒精性脂肪性肝病合并代谢综合征的预测价值及多因素Logistic决策树分析[J]. 中国全科医学, 2022, 25(17): 2126-2134.